Medina Medical Center

Medina Medical was a medical technology company focused on developing innovative solutions for the treatment of neurovascular diseases, specifically cerebral aneurysms. The company's core technology, the Medina Embolization Device, is a 3D self-expanding mesh that provides a scaffold for the treatment of wide-neck and complex aneurysms. This device was designed to offer a more effective alternative to traditional embolic coiling by improving occlusion rates and reducing procedure complexity. Founded in 2009 and headquartered in Menlo Park, California, Medina Medical was acquired by Medtronic in 2015 for $150 million upfront plus additional milestone payments. The acquisition allowed Medtronic to integrate Medina's advanced embolization technology into its neurovascular portfolio, addressing a significant unmet need in stroke and aneurysm care.